摘要硝苯地平为一种钙拮抗剂。本文对其不良反应的研究进展作一综述,以期引起临床工作者的注意。Nifedipine is a calcium antagonist. The adverse reactions of it are reviewed in order to cause the attention of the clinical workers.
2Toner M, Wnile A, Moriarty J. Allergic urticarial eruption, leukocytosis, and abnormal liver function tests following nifedipine administration. Chest,1988, 93(6):1302.
3Reynolds NJ, Jones SK, Crcssley J. Exfoliative dermatitis to nifedipine. Br J Dermatol, 1989,12(3):401.
4Parish LC, Witkowski JA. Truneal morbilliform eruption due to nifedipine. Cutis, 1992,49:113.
5Crowson AN, Magro CM. Subacute cutaneous lupus erythematosus arising in the setting of calcicum channel blocker therapy. Hum Pathol, 1997, 28: 67.
6Kitamura K, Kanasashi M, Suga C. Cutaneous reactions induced by calcicum channel blocker: high frequency of psoriasiforrn eruptions. J Dermatol, 1993,20:279.
7Stern R, Khalsa H. Cutaneous adverse reactions associated with calcium channel blockers. Archives of Internal Medicine, 1989,149:829.
